Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Telomere Molecular Epidemiology

Highlights from "Telomere Biology and Cancer Risk"

Highlights from "Telomere Biology and Cancer Risk"

The Clinical Genetics Branch studies families with dyskeratosis congenita (DC), a rare and complex inherited cancer predisposition syndrome. 

Telomeres, specialized structures consisting of long DNA nucleotide repeats and a protein complex, are designed to protect the ends of chromosomes and are critical to chromosome stability. Each time a cell divides, the telomeres lose a small amount of DNA and become shorter. Eventually, telomeres become critically short, causing cellular senescence or cellular crisis, which result in apoptosis, genomic instability or a reduction in cellular lifespan. If cells bypass natural processes and continue to divide despite the presence of genomic instability, cancer can develop. DCEG investigators have been studying telomeres and their associations with cancer risk. Types of studies include

Dyskeratosis Congenita Study

DCEG studies of dyskeratosis congenita, an inherited bone marrow failure syndrome and cancer predisposition disorder characterized by abnormalities in telomere biology

Genetic Contribution to Telomere Biology

Studies of possible germline genetic variations in genes that code for proteins integral in telomere biology, which may be important in cancer etiology

For more information, contact Sharon Savage.

Clinical Genetics Branch - Research Areas

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Telomere Molecular Epidemiology was originally published by the National Cancer Institute.”

Email